Daley-Yates, Peter
Keppler, Brian
Baines, Amanda
Bardsley, George
Fingleton, James
Clinical trials referenced in this document:
Documents that mention this clinical trial
Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial
https://doi.org/10.1186/s12931-022-02164-w
Funding for this research was provided by:
GlaxoSmithKline plc. (Study number 201499)
Article History
Received: 19 March 2021
Accepted: 2 September 2022
First Online: 20 September 2022
Declarations
:
: Prospective ethics approval was obtained from the Health and Disability Ethics Committees, New Zealand (Reference 16/STH/13).
: Not applicable.
: GB has no conflicts of interest to declare. JF reports grants from GSK during the conduct of the study; grants, personal fees and non-financial support from AstraZeneca; grants from Genentech; and personal fees and non-financial support from GSK and Boehringer Ingelheim. AB and PDY are employees of, and shareholders in, GSK BK is an employee of Metabolon, Inc, which received funding from GSK to conduct the study.